Detalhe da pesquisa
1.
Neo-peripheral adaptive immune score predicts neoadjuvant chemotherapy for locally advanced breast cancer.
Breast Cancer Res Treat
; 197(2): 343-354, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409395
2.
Aspirin Blocks the Infarct-Size Limiting Effect of Ischemic Postconditioning in the Rat.
Cardiovasc Drugs Ther
; 37(2): 221-224, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403016
3.
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes.
Cardiovasc Drugs Ther
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914900
4.
Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury.
Cardiovasc Drugs Ther
; 37(4): 625-646, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192075
5.
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes.
Cardiovasc Drugs Ther
; 36(6): 1091-1108, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448973
6.
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
Cardiovasc Drugs Ther
; 36(5): 829-840, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232433
7.
Diagnosis of Occlusion Myocardial Infarction in Patients with Left Bundle Branch Block and Paced Rhythms.
Curr Cardiol Rep
; 23(12): 187, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791609
8.
Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
Cardiovasc Drugs Ther
; 34(6): 835-848, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767170
9.
Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
Cardiovasc Drugs Ther
; 34(4): 443-461, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335797
10.
Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion.
Cell Physiol Biochem
; 53(6): 961-981, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820856
11.
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.
Basic Res Cardiol
; 114(5): 35, 2019 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388770
12.
The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury.
Cardiovasc Drugs Ther
; 33(4): 489-498, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332654
13.
Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
Cell Physiol Biochem
; 50(2): 552-568, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308506
14.
Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy.
Cell Physiol Biochem
; 46(6): 2284-2296, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29734191
15.
SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials.
Curr Diab Rep
; 18(9): 63, 2018 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995242
16.
Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation.
Cardiovasc Drugs Ther
; 32(6): 553-558, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367338
17.
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials.
Cardiovasc Drugs Ther
; 32(1): 65-72, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29445896
18.
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Cardiovasc Drugs Ther
; 32(2): 135-145, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508169
19.
Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice.
Cardiovasc Drugs Ther
; 31(5-6): 489-500, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29185103
20.
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
Cardiovasc Drugs Ther
; 31(2): 119-132, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447181